Titre : Noma

Noma : Questions médicales fréquentes

Termes MeSH sélectionnés :

Network Meta-Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Noma : Questions médicales les plus fréquentes", "headline": "Noma : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Noma : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-26", "dateModified": "2025-04-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Noma" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies de la bouche", "url": "https://questionsmedicales.fr/mesh/D009059", "about": { "@type": "MedicalCondition", "name": "Maladies de la bouche", "code": { "@type": "MedicalCode", "code": "D009059", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C07.465" } } }, "about": { "@type": "MedicalCondition", "name": "Noma", "alternateName": "Noma", "code": { "@type": "MedicalCode", "code": "D009625", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Elise Farley", "url": "https://questionsmedicales.fr/author/Elise%20Farley", "affiliation": { "@type": "Organization", "name": "Noma Children's Hospital, Médecins Sans Frontières, Sokoto, Nigeria." } }, { "@type": "Person", "name": "Tetsushi Ono", "url": "https://questionsmedicales.fr/author/Tetsushi%20Ono", "affiliation": { "@type": "Organization", "name": "Faculty of Veterinary Medicine, Okayama University of Science, Ehime 794-8555, Japan." } }, { "@type": "Person", "name": "Eri Iwata", "url": "https://questionsmedicales.fr/author/Eri%20Iwata", "affiliation": { "@type": "Organization", "name": "Faculty of Veterinary Medicine, Okayama University of Science, Ehime 794-8555, Japan." } }, { "@type": "Person", "name": "Emi Ohzawa", "url": "https://questionsmedicales.fr/author/Emi%20Ohzawa", "affiliation": { "@type": "Organization", "name": "Noma Horse Preservation Society, Ehime 794-0082, Japan." } }, { "@type": "Person", "name": "Hitoshi Kitagawa", "url": "https://questionsmedicales.fr/author/Hitoshi%20Kitagawa", "affiliation": { "@type": "Organization", "name": "Faculty of Veterinary Medicine, Okayama University of Science, Ehime 794-8555, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Kenward-Roger-type corrections for inference methods of network meta-analysis and meta-regression.", "datePublished": "2023-07-03", "url": "https://questionsmedicales.fr/article/37399845", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jrsm.1652" } }, { "@type": "ScholarlyArticle", "name": "Diagnostic yield and safety of diagnostic techniques for pulmonary lesions: systematic review, meta-analysis and network meta-analysis.", "datePublished": "2024-09-18", "url": "https://questionsmedicales.fr/article/39293856", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1183/16000617.0046-2024" } }, { "@type": "ScholarlyArticle", "name": "Topical anti-inflammatory treatments for eczema: network meta-analysis.", "datePublished": "2024-08-06", "url": "https://questionsmedicales.fr/article/39105474", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD015064.pub2" } }, { "@type": "ScholarlyArticle", "name": "Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis.", "datePublished": "2023-08-31", "url": "https://questionsmedicales.fr/article/37650547", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD013730.pub2" } }, { "@type": "ScholarlyArticle", "name": "Percutaneous coronary intervention in calcified stenoses: a protocol for a systematic review with meta-analysis, trial sequential analysis and network meta-analysis.", "datePublished": "2022-09-02", "url": "https://questionsmedicales.fr/article/36691161", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2022-063884" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système stomatognathique", "item": "https://questionsmedicales.fr/mesh/D009057" }, { "@type": "ListItem", "position": 3, "name": "Maladies de la bouche", "item": "https://questionsmedicales.fr/mesh/D009059" }, { "@type": "ListItem", "position": 4, "name": "Noma", "item": "https://questionsmedicales.fr/mesh/D009625" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Noma - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Noma", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Noma", "description": "Comment diagnostiquer le noma ?\nQuels tests sont utilisés pour le noma ?\nLe noma est-il visible à l'examen physique ?\nQuels signes cliniques indiquent le noma ?\nLe noma peut-il être confondu avec d'autres maladies ?", "url": "https://questionsmedicales.fr/mesh/D009625?mesh_terms=Network+Meta-Analysis&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Noma", "description": "Quels sont les symptômes du noma ?\nLe noma cause-t-il des douleurs ?\nY a-t-il des signes de malnutrition avec le noma ?\nLe noma entraîne-t-il une mauvaise haleine ?\nLe noma affecte-t-il l'appétit ?", "url": "https://questionsmedicales.fr/mesh/D009625?mesh_terms=Network+Meta-Analysis&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Noma", "description": "Comment prévenir le noma ?\nL'éducation sanitaire aide-t-elle à prévenir le noma ?\nLes vaccinations préviennent-elles le noma ?\nLe suivi médical régulier est-il important ?\nLes programmes de nutrition peuvent-ils réduire le risque de noma ?", "url": "https://questionsmedicales.fr/mesh/D009625?mesh_terms=Network+Meta-Analysis&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Noma", "description": "Comment traite-t-on le noma ?\nLes antibiotiques sont-ils efficaces contre le noma ?\nLa chirurgie est-elle nécessaire pour le noma ?\nLe traitement du noma nécessite-t-il une hospitalisation ?\nY a-t-il des traitements préventifs pour le noma ?", "url": "https://questionsmedicales.fr/mesh/D009625?mesh_terms=Network+Meta-Analysis&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Noma", "description": "Quelles sont les complications du noma ?\nLe noma peut-il entraîner des problèmes psychologiques ?\nLe noma peut-il affecter la croissance des enfants ?\nY a-t-il un risque de récidive du noma ?\nLe noma peut-il causer des infections secondaires ?", "url": "https://questionsmedicales.fr/mesh/D009625?mesh_terms=Network+Meta-Analysis&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Noma", "description": "Quels sont les facteurs de risque du noma ?\nLa malnutrition est-elle un facteur de risque pour le noma ?\nLes enfants sont-ils plus à risque de noma ?\nLes maladies chroniques augmentent-elles le risque de noma ?\nLe manque d'hygiène buccale est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D009625?mesh_terms=Network+Meta-Analysis&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer le noma ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et l'historique médical du patient." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le noma ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des prélèvements de tissus et des analyses sanguines peuvent être effectués." } }, { "@type": "Question", "name": "Le noma est-il visible à l'examen physique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il se manifeste par des ulcérations et des déformations faciales." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent le noma ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des lésions buccales, une douleur intense et une mauvaise haleine sont des signes." } }, { "@type": "Question", "name": "Le noma peut-il être confondu avec d'autres maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être confondu avec d'autres infections buccales ou faciales." } }, { "@type": "Question", "name": "Quels sont les symptômes du noma ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des ulcérations, une douleur faciale et une fièvre." } }, { "@type": "Question", "name": "Le noma cause-t-il des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il provoque des douleurs intenses dans la région affectée." } }, { "@type": "Question", "name": "Y a-t-il des signes de malnutrition avec le noma ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le noma est souvent associé à une malnutrition sévère chez les enfants." } }, { "@type": "Question", "name": "Le noma entraîne-t-il une mauvaise haleine ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une mauvaise haleine est fréquente en raison des lésions buccales." } }, { "@type": "Question", "name": "Le noma affecte-t-il l'appétit ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la douleur et les lésions peuvent réduire l'appétit du patient." } }, { "@type": "Question", "name": "Comment prévenir le noma ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut une nutrition adéquate et l'accès aux soins de santé." } }, { "@type": "Question", "name": "L'éducation sanitaire aide-t-elle à prévenir le noma ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'éducation sur l'hygiène buccale et la nutrition est cruciale." } }, { "@type": "Question", "name": "Les vaccinations préviennent-elles le noma ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de vaccin spécifique contre le noma, mais la vaccination aide à prévenir d'autres infections." } }, { "@type": "Question", "name": "Le suivi médical régulier est-il important ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi médical peut aider à détecter précocement les problèmes de santé." } }, { "@type": "Question", "name": "Les programmes de nutrition peuvent-ils réduire le risque de noma ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des programmes de nutrition ciblés peuvent diminuer le risque de noma chez les enfants." } }, { "@type": "Question", "name": "Comment traite-t-on le noma ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut des antibiotiques, des soins locaux et parfois une chirurgie." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils efficaces contre le noma ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antibiotiques sont essentiels pour contrôler l'infection." } }, { "@type": "Question", "name": "La chirurgie est-elle nécessaire pour le noma ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, une intervention chirurgicale peut être nécessaire pour réparer les tissus." } }, { "@type": "Question", "name": "Le traitement du noma nécessite-t-il une hospitalisation ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une hospitalisation est souvent nécessaire pour un traitement intensif." } }, { "@type": "Question", "name": "Y a-t-il des traitements préventifs pour le noma ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par une bonne nutrition et des soins bucco-dentaires." } }, { "@type": "Question", "name": "Quelles sont les complications du noma ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des déformations faciales, des infections systémiques et la mort." } }, { "@type": "Question", "name": "Le noma peut-il entraîner des problèmes psychologiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les déformations faciales peuvent causer des problèmes d'estime de soi et d'anxiété." } }, { "@type": "Question", "name": "Le noma peut-il affecter la croissance des enfants ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la malnutrition et l'infection peuvent entraver la croissance normale." } }, { "@type": "Question", "name": "Y a-t-il un risque de récidive du noma ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sans traitement adéquat et prévention, le noma peut récidiver." } }, { "@type": "Question", "name": "Le noma peut-il causer des infections secondaires ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'infection peut se propager et entraîner des infections secondaires graves." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du noma ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la malnutrition, l'immunodépression et le manque d'accès aux soins." } }, { "@type": "Question", "name": "La malnutrition est-elle un facteur de risque pour le noma ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la malnutrition est le principal facteur de risque pour développer le noma." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque de noma ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le noma touche principalement les enfants, surtout ceux en situation de précarité." } }, { "@type": "Question", "name": "Les maladies chroniques augmentent-elles le risque de noma ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies chroniques qui affaiblissent le système immunitaire augmentent le risque." } }, { "@type": "Question", "name": "Le manque d'hygiène buccale est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une mauvaise hygiène buccale peut favoriser l'apparition du noma." } } ] } ] }

Sources (10000 au total)

Diagnostic yield and safety of diagnostic techniques for pulmonary lesions: systematic review, meta-analysis and network meta-analysis.

With recent advancements in bronchoscopic procedures, data on the best modality to sample peripheral pulmonary lesions (PPLs) is lacking, especially comparing bronchoscopy with computed tomography-gui... We performed a meta-analysis, pairwise meta-analysis and network meta-analysis on studies reporting diagnostic yield and complications with the use of CT-TBNA, radial endobronchial ultrasound (rEBUS),... We included 363 studies. The overall pooled diagnostic yield was 78.1%, the highest with CT-TBNA (88.9%), followed by RAB (84.8%) and the least with rEBUS (72%). In the pairwise meta-analysis, only rE... Although CT-TBNA is the most effective approach to sample PPLs, RAB has a comparable diagnostic yield with a lesser complication rate. Further prospective studies are needed comparing CT-TBNA and RAB....

Topical anti-inflammatory treatments for eczema: network meta-analysis.

Eczema (atopic dermatitis) is the most burdensome skin condition worldwide and cannot currently be prevented or cured. Topical anti-inflammatory treatments are used to control eczema symptoms, but the... To compare and rank the efficacy and safety of topical anti-inflammatory treatments for people with eczema using a network meta-analysis.... We searched the Cochrane Skin Specialised Register, CENTRAL, MEDLINE, Embase and trial registries on 29 June 2023, and checked the reference lists of included studies.... We included within-participant or between-participant randomised controlled trials (RCTs) in people of any age with eczema of any severity, but excluded trials in clinically infected eczema, seborrhoe... We used standard Cochrane methods. Primary outcomes were patient-reported eczema symptoms, clinician-reported eczema signs and investigator global assessment. Secondary outcomes were health-related qu... We included 291 studies involving 45,846 participants with the full spectrum of eczema severity, mainly conducted in high-income countries in secondary care settings. Most studies included adults, wit... Potent TCS, JAK inhibitors and tacrolimus 0.1% were consistently ranked as amongst the most effective topical anti-inflammatory treatments for eczema and PDE-4 inhibitors as amongst the least effectiv...

Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis.

Despite considerable improvement in outcomes for preterm infants, rates of bronchopulmonary dysplasia (BPD) remain high, affecting an estimated 33% of very low birthweight infants, with corresponding ... To determine whether differences in efficacy and safety exist between high-dose dexamethasone, moderate-dose dexamethasone, low-dose dexamethasone, hydrocortisone, and placebo in the prevention of BPD... We searched the Cochrane Library for all systematic reviews of systemic corticosteroids for the prevention of BPD and searched for completed and ongoing studies in the following databases in January 2... We included randomized controlled trials (RCTs) in preterm infants (< 37 weeks' gestation) at risk for BPD that evaluated systemic corticosteroids (high-dose [≥ 4 mg/kg cumulative dose] dexamethasone,... Our main information sources were the systematic reviews, with reference to the original manuscript only for data not included in these reviews. Teams of two paired review authors independently perfor... We included 59 studies, involving 6441 infants, in our analyses. Only six of the included studies provided direct comparisons between any of the treatment (dexamethasone or hydrocortisone) groups, for... Low-dose dexamethasone increased the risk for cerebral palsy (RR 1.92, 95% CI 1.12 to 3.28; moderate-certainty evidence) compared with control. Hydrocortisone may decrease the risk of major neurosenso... No effect was observed for the outcomes of major neurosensory disability or cerebral palsy. The evidence for the primary outcomes was of overall low certainty, with notable deductions for imprecision ... While early treatment with moderate-dose dexamethasone or late treatment with high-dose dexamethasone may lead to the best effects for survival without BPD, the certainty of the evidence is low. There...

Percutaneous coronary intervention in calcified stenoses: a protocol for a systematic review with meta-analysis, trial sequential analysis and network meta-analysis.

Severely calcified coronary stenoses are difficult to treat with percutaneous coronary interventions. The presence of severe calcifications complicates lesion preparation, advancement of stents and ac... We will conduct a systematic review of randomised trials enrolling patients with calcified coronary artery disease undergoing percutaneous coronary intervention. We will investigate any percutaneous t... No ethics approval is required for this study. The results will be published in a peer-reviewed journal in this field.... CRD42021226034....

Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis.

Multiple sclerosis (MS) is a chronic disease of the central nervous system that affects mainly young adults (two to three times more frequently in women than in men) and causes significant disability ... To compare adverse effects of immunotherapies for people with MS or clinically isolated syndrome (CIS), and to rank these treatments according to their relative risks of adverse effects through networ... We searched CENTRAL, PubMed, Embase, two other databases and trials registers up to March 2022, together with reference checking and citation searching to identify additional studies.... We included participants 18 years of age or older with a diagnosis of MS or CIS, according to any accepted diagnostic criteria, who were included in randomized controlled trials (RCTs) that examined o... We used standard Cochrane methods for data extraction and pairwise meta-analyses. For NMAs, we used the netmeta suite of commands in R to fit random-effects NMAs assuming a common between-study varian... This NMA included 123 trials with 57,682 participants... We found mostly low and very low-certainty evidence that drugs used to treat MS may not increase SAEs, but may increase withdrawals compared with placebo. The results suggest that there is no importan...

Impact of SGLT2 inhibitors on patient outcomes: a network meta-analysis.

A comprehensive network meta-analysis comparing the effects of individual sodium-glucose cotransporter 2 (SGLT2) inhibitors on patients with and without comorbidities including diabetes mellitus (DM),... We searched PubMed, Embase, Cochrane, and ClinicalTrials.gov for randomized controlled trials up to March 28, 2023. Network meta-analysis using a random-effects model was conducted to calculate risk r... A total of fourteen trials with 75,334 patients were analyzed. Among these, 40,956 had taken SGLT2 inhibitors and 34,378 had not. One of the main results with particular findings was empagliflozin use... Our network meta-analysis revealed that empagliflozin users with diabetes experienced a lower risk of dying from any cause than those using dapagliflozin. Additionally, canagliflozin users demonstrate... PROSPERO [CRD42022361906]....

A network meta-analysis of surgical treatments of complete rectal prolapse.

Surgical treatment of complete rectal prolapse can be undertaken via an abdominal or a perineal approach. The present network meta-analysis aimed to compare the outcomes of different abdominal and per... A PRISMA-compliant systematic review of PubMed, Scopus, and Web of Science was conducted. Randomized clinical trials comparing two or more procedures for the treatment of complete rectal prolapse were... Nine randomized controlled trials with 728 patients were included. The follow-up ranged between 12 and 47 months. Posterior mesh rectopexy had significantly lower odds of recurrence than did the Altem... Posterior mesh rectopexy ranked best with the lowest recurrence while perineal procedures ranked worst with the highest recurrence rates....

Efficacy and safety of COVID-19 vaccines: A network meta-analysis.

Several vaccines showed a good safety profile and significant efficacy against COVID-19. Moreover, in the absence of direct head to head comparison between COVID-19 vaccines, a network meta-analysis t... Databases PubMed, CENTRAL, medRxiv, and clinicaltrials.gov were searched. Studies were included if they were placebo-controlled clinical trials and reported the safety profile and/or effectiveness of ... Forty-nine clinical trials that included 421,173 participants and assessed 28 vaccines were included in this network meta-analysis. The network meta-analysis showed that Pfizer is the most effective i... We found that almost all of the vaccines included in this study crossed the threshold of 50% efficacy. However, some of them did not reach the previously mentioned threshold against the B.1.351 varian...